Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
National Journal of Andrology ; (12): 315-319, 2015.
Article in Chinese | WPRIM | ID: wpr-319502

ABSTRACT

<p><b>OBJECTIVE</b>To explore the expressions of trefoil factor 1 (TFF1) and trefoil factor 3 (TFF3) in prostate cancer (PCa) and prostate intraepithelial neoplasia (PIN) and their clinical significance.</p><p><b>METHODS</b>Using immunohistochemistry, we detected the expressions of TFF1 and TFF3 in the prostatic tissues of 89 cases of PCa, 50 cases of PIN, and 65 cases of benign prostate hyperplasia (BPH), and evaluated their clinical significance.</p><p><b>RESULTS</b>The positive rates of TFF1 and TFF3 expressions were 77. 53% and 48. 31% in PCa and 66.00% and 30.00% in PIN, significantly higher than 49.23% and 13. 85% in BPH (P <0. 05). The expression of TFF1 was not correlated with Gleason score (P >0. 05), while that of TFF3 was significantly higher in the PCa cases with Gleason score ≤7 than in those with Gleason score > 7 (70. 00% vs 42. 03%, P <0. 05). No significant correlation was observed between TFF1 and TFF3 expressions in PCa (P >0. 05).</p><p><b>CONCLUSION</b>The expressions of TFF1 and TFF3 may contribute to the occurrence and progression of PCa, and therefore could be used as laboratory indexes in the diagnosis, differential diagnosis, and prognosis of PCa.</p>


Subject(s)
Humans , Male , Disease Progression , Immunohistochemistry , Peptides , Metabolism , Prognosis , Prostatic Hyperplasia , Metabolism , Prostatic Intraepithelial Neoplasia , Metabolism , Prostatic Neoplasms , Metabolism , Trefoil Factor-1 , Trefoil Factor-3 , Tumor Suppressor Proteins , Metabolism
2.
National Journal of Andrology ; (12): 320-324, 2015.
Article in Chinese | WPRIM | ID: wpr-319501

ABSTRACT

<p><b>OBJECTIVE</b>To explore the expression of the epithelial cell adhesion molecule (EpCAM) in prostate cancer (PCa) and its clinical significance.</p><p><b>METHODS</b>We collected tissue samples from 63 cases of PCa, 46 cases of prostatic intraepithelial neoplasia (PIN), and 58 cases of benign prostatic hyperplasia (BPH) adjacent to PCa and determined the expression of EpCAM in the epithelial and stromal cells by immunohistochemistry.</p><p><b>RESULTS</b>The positive expression rates of EpCAM in the epithelial cells were significantly higher in PCa and PIN than in PCa-adjacent BPH (98. 4 and 97. 8 vs 51.7%, P <0. 01), and so was that in the stromal cells of PCa than in those of PCa-adjacent PIN (89.5 vs 50.0%, P <0.01). The expression of EpCAM.was remarkably higher in the stromal cells of bone metastasis than in those of non-bone metastasis tissue (100. 0 vs 40. 0%, P <0. 01) but showed no statistically significant differences between the highly and poorly differentiated PCa tissues (88.5 vs 91.9%, P >0.05).</p><p><b>CONCLUSION</b>The expression level of EpCAM in the stromal cells of PCa is related to the occurrence, progression, and bone metastasis of the tumor, and therefore may be used as a marker in the early diagnosis of PCa as well as a predictor of bone metastasis of the tumor.</p>


Subject(s)
Humans , Male , Antigens, Neoplasm , Metabolism , Biomarkers , Metabolism , Bone Neoplasms , Metabolism , Cell Adhesion Molecules , Metabolism , Disease Progression , Epithelial Cell Adhesion Molecule , Epithelial Cells , Metabolism , Immunohistochemistry , Prostatic Hyperplasia , Metabolism , Prostatic Intraepithelial Neoplasia , Metabolism , Prostatic Neoplasms , Metabolism , Stromal Cells , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL